Cancer drug could prevent paedophiles from offending
May 19th 2016
‘What is considered a negative side effect when you treat patients with prostate cancer, reduced sexual drive, we use as the wanted effect in this [paedophilic disorder] patient population.’
Researchers in Sweden have launched a crowdfunding campaign to raise money for a clinical trial which would test the efficacy of an anticancer drug in the treatment of male paedophiles.
The drug, Degarelix, reduces the amount of testosterone produced by the testes. A reduction in testosterone is beneficial firprostate cancer patients as the hormone promotes the growth of tumours. One side-effect of treatment is reduced sexual drive, an effect that Dr Christoffer Rahm hopes to his advantage in the treatment of paedophiles. Along with self-correction and empathy, levels of sexual arousal are considered to be key risk factors that determine whether someone with paedophilic disorder will offend.
Alice Williamson reports.
‘With this medicine we might actually reduce these risk factors, thereby reducing the risk of someone with paedophilic disorder committing sexual abuse’
The team at the Karolinska Institute are running the Priotab project and overseeing a double blind clinical trial for 60 men, recruited on a helpline affiliated with the institute, PrevenTell. This is the first trial of it’s kind for paedophilic disorder and is necessary in order to find scientific proof for the efficacy and safety of a new medicine for ‘chemical castration’. The use of placebos has raised some ethical concerns owing to the fact that some of the patients may be at risk of offending, but Dr Rahm explained that ‘the participants in this study are better monitored that patients in regular treating programs for paedophilia.’
Degarelix works much more quickly than other chemical castration drugs and without the dangerous spike in testosterone levels seen in other medicines.
‘Degarelix has an immediate onset of effect, in only 3 days following the injection, 97% of the men have no or almost no detectable levels of testosterone left in the blood and there is no initial flare.’
Money for the trial is being raised on a crowdfunding platform, which leaves the researchers free to investigate the drug without any constraints or potential conflicts of interest from the manufacturer.
In addition to the clinical trial, the Priotab project will look for biomarkers such as molecules in the blood or patterns in brain activity that could serve as further indicators of risk in male paedophilic disorder.
Find out more at their YouTube page.
Oscar is Backchat‘s digital producer.Read more from Oscar Coleman
Backchat: Police caution needed in COVID public health enforcement
Samantha Lee from Redfern Legal Centre spoke to Backchat about increased police powers during lockdown.
Backchat: To date or not to date within your faith?
A study last year found that one in three marriages were interracial, but when it comes to interfaith relationships, it’s a different story.
Gallery: School Strike 4 Climate 2021
The Backchat team attended the School Strike 4 Climate protest on Friday, May 21 2021.
Gallery: Free Palestine Nakba Day Rally 2021
The Backchat team attended the ‘#SaveSheikhJarrah, Free Palestine, Commemorate Al Nakba’ protest on Saturday, May 15 2021.
Gallery: Aboriginal Deaths In Custody Rally 2021
Backchat photographer Christopher Hanna captured the 30th Anniversary of the Royal Commission Into Aboriginal Deaths In Custody.
Backchat: #SAVEMYANMAR & The Myanmar Diaspora
“One day we were students doing TikTok and playing games, the next day we’re fighting…for our vote and our independence.”
Backchat: Why white feminism doesn’t stack up
“I feel like in some ways, I’ve been researching this book my whole life, unintentionally and unconsciously,” says Koa Beck.
Gallery: Invasion Day Sydney Rally 2021
The Backchat team captured the 2021 Invasion Day rally at Djarrbarrgalli.
The Delivery Riders Dying To Work
Tanita Razaghi reports on the preventable deaths of food delivery riders due to unsafe working conditions.